Letters Section Editor: Robert M. Golub, MD, Senior Editor.
To the Editor: Atrial fibrillation (AF) is the most common arrhythmia leading to patient hospitalization.1,2 In their Clinical Review, Drs Vassallo and Trohman3 discuss the use of amiodarone for treatment of AF. They state that “because AFFIRM demonstrated no significant differences in stroke, quality of life, or mortality with rhythm vs rate control, physicians must consider the risk-benefit ratio of antiarrhythmic drugs to maintain sinus rhythm.”
Kapoor JR. Use of Amiodarone. JAMA. 2007;298(22):2617–2618. doi:10.1001/jama.298.22.2617-a
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: